| 1 |
2023.07.31_DR_S.O. 3448(E)_Prohibition of Veterinary Drugs Ketoprofen and its formulation and Aceclofenac its Formulation |
2023-Jul-31 |
|
1085 KB |
| 2 |
2023.06.02_DR_ Final G.S.R 410(E)_Notification of Gangavaram Port |
2023-Jun-02 |
|
1130 KB |
| 3 |
2023.06.02_DR_S.O. 2394(E) to 2407(E)_Banning of 14 FDCs |
2023-Jun-02 |
|
1209 KB |
| 4 |
2023.05.15_S.O. 2191(E)_NIB Government Analyst Notification. |
2023-May-15 |
|
603 KB |
| 5 |
S.O. 2177(E) dt_11.05.2023_Government Analyst Notification at CDL, Kolkata |
2023-May-11 |
|
618 KB |
| 6 |
11.05.2023_DR_S.O. 2177(E) _Government Analyst Notification at CDL, Kolkata |
2023-May-11 |
|
618 KB |
| 7 |
nTHE DRUGS RULES 1945 |
2023-Apr-12 |
|
6332 KB |
| 8 |
THE DRUGS RULES 1945 |
2022-Nov-22 |
|
4983 KB |
| 9 |
2022.11.02_S.O. 5090(E)_Notification of eligible officers at CDTL Chennai as Govt Analyst under section 20 of the Drugs and Co |
2022-Nov-02 |
|
1357 KB |
| 10 |
DR_G.S.R. 654(E) dt_24.08.2022_Parallel submission in Form 28-D |
2022-Aug-24 |
|
1242 KB |
| 11 |
DR_G.S.R. 623(E) dt_10.08.2022_To include colour of disinfectants in rule 127 of Drugs Rules 1945 |
2022-Aug-10 |
|
1033 KB |
| 12 |
2022.08.10_S.O. 3757(E)_Notification of Director Incharge of CDL Kolkata |
2022-Aug-10 |
|
1454 KB |
| 13 |
DR_G.S.R. 502(E) dt_30.06.2022_Proviso to Sr.no 39 in Sch K for Liquid Antiseptics in Drugs Rules |
2022-Jun-30 |
|
1289 KB |
| 14 |
DR_G.S.R. 357(E) dt_18.05.2022_Inclusion of Acitretin in Sch H of Drugs Rules 1945 |
2022-May-18 |
|
1314 KB |
| 15 |
DR_G.S.R. 158(E) dt_24.02.2022_Inclusion of allura red colour in rule 127 of the Drugs Rules 1945 |
2022-Feb-24 |
|
1423 KB |
| 16 |
DR_G.S.R. 30(E) dt_20.01.2022_Amendment of Sch K for Liquid Antiseptics at Sr. no 39 in Drugs Rules |
2022-Jan-20 |
|
1367 KB |
| 17 |
DR_G.S.R. 20(E) dt_18.01.2022_QR code for active pharmaceutical ingredients |
2022-Jan-18 |
|
1549 KB |
| 18 |
2021.12.10_S.O. 5139(E)_Renotification of NIB Noida as CDL for testing and lot release of COVID 19 vaccine |
2021-Dec-10 |
|
11378 KB |
| 19 |
DR_G.S.R. 839(E) dt_29.11.2021_Amendment of rule 24 and 24A , 1945 to omit provisions for issuing duplicate copy of the Im |
2021-Nov-29 |
|
1623 KB |
| 20 |
DR_G.S.R. 848(E) dt_09.12.2021_Notification of ICD Tihi,M.P. in rule 43A of Drugs Rules |
2021-Nov-09 |
|
1080 KB |
| 21 |
2021.11.02_S.O. 4601(E)_Implementation date for provision of clause 2 of Explanation of Section 22 of the FSSA 2006 |
2021-Nov-02 |
|
890 KB |
| 22 |
DR_G.S.R. 762(E) dt_27.10.2021 reg Oxytocin API import exclusivelyfor mfg for export purpose only |
2021-Oct-27 |
|
1274 KB |
| 23 |
DR_G.S.R. 766(E) dt_21.10.2021_reg Rule 90,Form 29 deemed approval |
2021-Oct-21 |
|
1173 KB |
| 24 |
2021.10.18_S.O. 4326(E)_Reconstitution of DTAB 2021 |
2021-Oct-18 |
|
1220 KB |
| 25 |
2021.08.17_S.O. 3364(E NIAB Hyderabad |
2021-Aug-17 |
|
1245 KB |
| 26 |
2021.06.28_SO 2609(E)_Notification of NCCS Pune for COVID Vaccine testing valid till one year |
2021-Jun-28 |
|
1460 KB |
| 27 |
2021.06.22_SO 2451(E)_Notification of Sumir Rai Bhalla as GA for CDL Kasauli |
2021-Jun-22 |
|
1160 KB |
| 28 |
2021.06.22_SO 2449(E)_Notification of 14 Govt Analysts for CDTL Mumbai |
2021-Jun-22 |
|
1366 KB |
| 29 |
2021.06.22_SO 2450(E)_Notification of Dilip Kr Panda & Suparna Maitra as GA for CDL Kolkata |
2021-Jun-22 |
|
1127 KB |
| 30 |
2021.04.08_S.O. 1521(E)_Amendment of S.O. 2808(E) dt 30.11.2012 for including three more GA in previous list |
2021-Apr-08 |
|
1625 KB |
| 31 |
2021.04.07_S.O. 1520(E)_Notification of Raghuram Reddy Adidala, CDTL Hyderabad |
2021-Apr-07 |
|
1753 KB |
| 32 |
DR_G.S.R. 255(E) dt_07.04.2021_For substitution at entry no 14. of GSR 578(E) dt 23.07.1983 reg FDC of tamsulosin+Deflazacort |
2021-Apr-07 |
|
1508 KB |
| 33 |
DR_G.S.R. 258(E) dt_07.04.2021_ Inclusion of Tapentadol in Sch H1 at S.No. 48 |
2021-Apr-07 |
|
1225 KB |
| 34 |
2021.03.19_S.O.1260(E)_Notification of Debasis Maitti and Hitesh Khare as Govt. Analysts at RDTL Chandigarh |
2021-Mar-19 |
|
1263 KB |
| 35 |
2021.03.12_S.O. 1170(E)_Notifying Amar jyoti, Dilip Kr, Rinku & Arun Kr at RDTL Guwahati as Govt. analyst |
2021-Mar-12 |
|
1452 KB |
| 36 |
DR_G.S.R. 140(E) dt_26.02.2021_Schedule K at serial number 23 to include Anganwadi worker |
2021-Feb-26 |
|
1369 KB |
| 37 |
2021.02.04_S.O. 529(E)_Notification of Dr. Sandeep Singh & Dr. Sweta Raghuvanshi for Scepticemia and Rankhet Vaccines |
2021-Feb-04 |
|
1578 KB |
| 38 |
DR_G.S.R. 47(E) dt_25.01.2019_Exemption of 100mL single use sterile parenteral solutions for export under Schedule K |
2021-Jan-25 |
|
2426 KB |
| 39 |
2020.11.26_S.O. 4244(E)_Extension of Import license amid COVID-19 Pandemic for 6 months |
2020-Nov-26 |
|
1348 KB |
| 40 |
2020.11.24_S.O. 4206(E)_Notifying of NIB Noida for testing COVID-19 Vaccine |
2020-Nov-24 |
|
1265 KB |
| 41 |
2020.07.27_S.O. 2451(E)_Exemption of hand sanitizer from sale licence_Section 26B |
2020-Jul-27 |
|
1106 KB |
| 42 |
2020.07.27_S.O. 2450(E)_Reg. validity of existing Registration Certificate for import of drugs__Section 26B |
2020-Jul-27 |
|
1010 KB |
| 43 |
2020.05.18_S.O.1511(E)_Regulations for manufacture and stock of vaccines for COVID-19_Section 26B |
2020-May-18 |
|
1120 KB |
| 44 |
DR_G.S.R. 220(E) dt_26.03.2020_Doorstep delivery of the drugs by retail _Section 26B |
2020-Mar-26 |
|
1343 KB |
| 45 |
DR_G.S.R. 219(E) dt_26.03.2020_Sale of Hydroxychloroquine as per Schedule H1_Section 26B |
2020-Mar-26 |
|
1190 KB |
| 46 |
DR_G.S.R. 166(E) dt_18.03.2020_Amendment in Part X B & Part XII B pertains to Blood centre and Blood components |
2020-Mar-18 |
|
2014 KB |
| 47 |
DR_G.S.R. 180 (E) dt_16.03.2020_Banning of Chenodeoxycholic acid & Ursodeoxycholic acid extracted and prepareunder Section 10A |
2020-Mar-16 |
|
773 KB |
| 48 |
DR_G.S.R. 101(E) dt_13.02.2020_Definition, Responsibility & labelling requirements for marketer of the drugs |
2020-Feb-13 |
|
787 KB |
| 49 |
2020.01.31_S.O. 481(E)_Sushil Kumar Sahu GA, CDL Kasauli |
2020-Jan-31 |
|
935 KB |
| 50 |
DR_G.S.R. 52(E) dt_27.01.2020_Exemption of Import of Oxytocin reference standards from Prohibition |
2020-Jan-27 |
|
745 KB |
| 51 |
DR_G.S.R. 828(E) dt_06.11.2019_Condition of licence for undertaking on brand or trade names of drugs under D & C Rules, 1945 |
2019-Nov-06 |
|
332 KB |
| 52 |
DR_G.S.R. 653(E) dt_13.09.2019_Notification of ICD Dhannad Indore in MP for import of drugs under Rule 43A |
2019-Sep-13 |
|
242 KB |
| 53 |
DR_G.S.R. 499(E) dt_17.07.2019_Consesquential amendments to GSR 1337(E) Dt. 27.10.2017 |
2019-Jul-17 |
|
361 KB |
| 54 |
DR_G.S.R. 317(E) dt_18.04.2019_Amendment in Form 45 and Form 46 under Schedule-A of D&C Rules, 1945 |
2019-Apr-18 |
|
322 KB |
| 55 |
DR_G.S.R. 231(E) dt_20.03.2019_Addition of Rule 97A |
2019-Mar-20 |
|
306 KB |
| 56 |
DR_G.S.R.223(E) dt_18.03.2019_Inclusion of Form 39A_Report of analysis by approved institution for individual or organization or procurement agency |
2019-Mar-18 |
|
346 KB |
| 57 |
DR_G.S.R.213(E) dt_11.03.2019_Notifcation of CCSNIAH, Baghpat, UP for testing of Veterinary Vaccines |
2019-Mar-11 |
|
318 KB |
| 58 |
DR_G.S.R. 205(E) dt_08.03.2019_Omission of provision for writing brand name in brackets in Rule 96 of D &C Rules, 1945 |
2019-Mar-08 |
|
302 KB |
| 59 |
DR_G.S.R.186(E) dt_06.03.2019_Hydroquinone included in Note to Schedule H of D&C Rules, 1945 |
2019-Mar-06 |
|
289 KB |
| 60 |
DR_G.S.R. 153(E) dt_26.02.2019_Date of implementation for G.S.R. 277(E) dated 23.03.2018 |
2019-Feb-26 |
|
315 KB |
| 61 |
2019.02.05_S.O. 697(E)_Revoke of FDC banned notification S.O. 4616(E) dated 07.09.2018_Section 26A |
2019-Feb-05 |
|
282 KB |
| 62 |
2019.01.11_S.O. 180(E) to S.O.259(E)_Prohibition of certain FDCs appeared in the list of 294 FDCs, under Section 26A |
2019-Jan-11 |
|
1964 KB |
| 63 |
DR_G.S.R. 19(E) dt_10.01.2019_Provosion for information to be uploaded by licensee on SUGAM portal |
2019-Jan-10 |
|
328 KB |
| 64 |
DR_G.S.R. 20(E) dt_10.01.2019_Notification of Mundra port and Kamarajar Port under Rule 43A |
2019-Jan-10 |
|
292 KB |
| 65 |
2018.12.30_S.O. 3909 Aurvedic, Siddha and Unani Drugs Consultative Committee |
2018-Dec-30 |
|
142 KB |
| 66 |
DR_G.S.R. 1230(E) dt_21.12.2018_Rule 170_Prohibition of advt. of Aurvedic, Siddha and Unani Drugs_AYUSH |
2018-Dec-21 |
|
433 KB |
| 67 |
2018.12.13_S.O. 6161(E) _ Restriction of Buclizine and its formulations as appetite stimulant under Section 26A |
2018-Dec-13 |
|
286 KB |
| 68 |
DR_G.S.R. 1193(E) dt_12.12.2018_Fee Revision for registration & import license under D&C Rules, 1945 |
2018-Dec-12 |
|
312 KB |
| 69 |
DR_G.S.R.1186(E) dt_07.12.2018_ Approved or permitted color in gelatine capsule Rule127(2) |
2018-Dec-07 |
|
306 KB |
| 70 |
DR_G.S.R. 1161(E) dt_03.12.2018_Amendment in Rule 96 & Date of implemention of GSR 222(E) dated 13.03.2018 |
2018-Dec-03 |
|
308 KB |
| 71 |
DR_G.S.R. 1074(E) dt_30.10.2018_Prohibition of import of Rapid Diagnostic Tests for Malaria_Section 10A |
2018-Oct-30 |
|
299 KB |
| 72 |
2018.09.07_S.O. 4379(E) to S.O.4712 (E)_Prohibition & Restriction of FDC drugs_Section 26A |
2018-Sep-07 |
|
7414 KB |
| 73 |
DR_G.S.R. 794(E) and G.S.R. 795(E)_Mfg of Oxytocin Formulation & Scheduling of Oxytocin in Sch H1 & omittion from Sch H |
2018-Aug-21 |
|
1705 KB |
| 74 |
DR_G.S.R. 521(E) dt_01.06.2018_Form12B_Extended validity of personal import licence |
2018-Jun-01 |
|
1757 KB |
| 75 |
2018.05.15_ S.O. 1929(E)_Reconstitution of DTAB 2018 |
2018-May-15 |
|
1778 KB |
| 76 |
DR_G.S.R. 602(E) dt_29.06.2018_Extention of implementation date for GSR 411(E) dated 27.04.2018 |
2018-Apr-27 |
|
1749 KB |
| 77 |
DR_G.S.R. 411(E) dt_27.04.2018_ Regulation and restriction of the manufacture, sale & distribution of Oxytocin under Section 26A |
2018-Apr-27 |
|
1756 KB |
| 78 |
DR_G.S.R. 408 (E) dt_26.04.2018_amendment of Rule 96, Rule 97 , Sch H & Sch K |
2018-Apr-26 |
|
1795 KB |
| 79 |
DR_G.S.R. 390(E) dt_24.04.2018_Prohibit the import of Oxytocin under Section 10A |
2018-Apr-24 |
|
1721 KB |
| 80 |
DR_G.S.R. 385(E) dt_19.04.2018_Amendment of Sch-K to exempt Oxygen 93% IP |
2018-Apr-19 |
|
1780 KB |
| 81 |
DR_G.S.R. 360(E) dt_10.04.2018_Stability study of drugs & Sch.D exemption |
2018-Apr-10 |
|
1730 KB |
| 82 |
DR_G.S.R. 277(E) dt_23.03.2018_Inclusion of drugs in Sch. H |
2018-Mar-23 |
|
1707 KB |
| 83 |
DR_G.S.R. 222(E) dt_13.03.2018_ Rule 96_Amendment of proper name font size |
2018-Mar-13 |
|
1689 KB |
| 84 |
DR_G.S.R. 1380(E) dt_10.11.2017_Homoeopathy-Amendment of Drugs and Cosmetic Rules |
2017-Nov-10 |
|
1645 KB |
| 85 |
DR_G.S.R. 1337(E) dt_27.10.2017_Perpetual Licensing and Joint Inspection |
2017-Oct-27 |
|
1625 KB |
| 86 |
2017.06.08_S.O 1851(E) ,1852(E) ,1853(E) ,1854(E) and 1855(E)_Irrrationlity of FDC |
2017-Jun-08 |
|
1727 KB |
| 87 |
DR_G.S.R. 367(E) dt_13.04.2017_Revoke of suspension on dextropropoxyphene |
2017-Apr-13 |
|
1157 KB |
| 88 |
DR_G.S.R. 328(E) dt_03.04.2017_Rule 122P_Blood banks and Blood Donation Camps |
2017-Apr-03 |
|
299 KB |
| 89 |
DR_G.S.R. 329(E) dt_03.04.2017_Form44_Particulars of new drug entries omitted |
2017-Apr-03 |
|
1202 KB |
| 90 |
DR_G.S.R. 327(E) dt_03.04.2017_BCS Classification and BABE studies |
2017-Apr-03 |
|
1205 KB |
| 91 |
DR_G.S.R. 303(E) dt_30.03.2017_Shedule H_Etizolam was included |
2017-Mar-30 |
|
1149 KB |
| 92 |
DR_G.S.R. 250(E) dt_15.03.2017_Insertion to Rule 3A_Added tests notified for NIB |
2017-Mar-15 |
|
1156 KB |
| 93 |
DR_G.S.R. 145(E) dt_17.02.2017_Revoke of suspension on Letrozole |
2017-Feb-17 |
|
1131 KB |
| 94 |
DR_G.S.R. 144(E) dt_17.02.2017_Regulation of Oseltamivir Phosphate and Zanamivir |
2017-Feb-17 |
|
1132 KB |
| 95 |
DR_G.S.R. 103 (E) dt_02.02.2017_Addition of Rule 36A_Import of drugs by charitable hospital for free of cost |
2017-Feb-02 |
|
1121 KB |
| 96 |
DR_G.S.R. 76(E) dt_31.01.2017_Amendment SchK_Exemptions of Homeopathic hair oils,Custom made devices,Zinc sulphate Tabs |
2017-Jan-31 |
|
1125 KB |
| 97 |
DR_G.S.R. 56(E) dt_19.01.2017_Amendment Rule 135A, 145D_Limit of Mercury in cosmetics |
2017-Jan-19 |
|
1107 KB |
| 98 |
DR_G.S.R. 41(E) dt_17.01.2017_Notification for Hazira port and ICD Khodiyar Gandhi nagar |
2017-Jan-17 |
|
1136 KB |
| 99 |
DR_G.S.R. 1041(E) dt_04.11.2016_Amendment Schedule Y Apeendix III_Animal Toxicity |
2016-Nov-04 |
|
962 KB |
| 100 |
DR_G.S.R. 897(E) dt_21.09.2016_WHO-COPP |
2016-Sep-21 |
|
240 KB |
| 101 |
DR_G.S.R. 640(E) dt_29.06.2016_Sch MIII(Rule 69, 69A,75,75A,76)_Quality management system for notified Medical devices |
2016-Jun-29 |
|
495 KB |
| 102 |
DR_G.S.R. 532(E) dt_18.05.2016_Addition of Vishakhapatnam Sea and air port |
2016-May-18 |
|
164 KB |
| 103 |
2016.05.04_S.O. 1326(E)_Notification for Government Analyst_Dr. Raman Mohan Singh, Dir, CDTL, Mumbai |
2016-May-04 |
|
33 KB |
| 104 |
DR_G.S.R. 313 (E) dt_16.03.2016_Amendment Rule 122DA_Ethics Committee |
2016-Mar-16 |
|
131 KB |
| 105 |
2016.03.10_S.O.705-1048_344 FDC_26A |
2016-Mar-10 |
|
2744 KB |
| 106 |
DR_G.S.R. 287(E) dt_08.03.2016_Amendment SchY_PSUR, Systemic Toxicity studies |
2016-Mar-08 |
|
151 KB |
| 107 |
DR_G.S.R. 104 (E) dt_25.01.2016_corrigendum to GSR 826 |
2016-Jan-25 |
|
66 KB |
| 108 |
DR_G.S.R. 918(E) dt_30.11.2015_Amendment Rule 2,122A,122B_Data to be submitted for Phytopharmaceuticals for CT |
2015-Nov-30 |
|
124 KB |
| 109 |
DR_G.S.R. 826 (E) dt_30.10.2015_Amendment Rule 122DA_Substitution of Explanation_122DAA omitted |
2015-Oct-30 |
|
179 KB |
| 110 |
2015.09.02_S.O. 2393(E)_Notification for Government Analyst |
2015-Sep-02 |
|
66 KB |
| 111 |
DR_G.S.R. 611(E) dt_31.07.2015_Amendment SchY_Relating to Informed Consent |
2015-Jul-31 |
|
93 KB |
| 112 |
DR_G.S.R. 558(E) dt_17.07.2015_Amendment Rule 105_amendment in proviso and proviso added for Diclofenac Inj |
2015-Jul-17 |
|
140 KB |
| 113 |
SO 1597(E) dt 16.06.2015_Notification of Smt. Kiran Pandey at CRI Kasauli as GA |
2015-Jun-16 |
|
96 KB |
| 114 |
DR_G.S.R. 390(E) dt_18.05.2015_Amendment Rule 157_No prefix & suffix for Aurvedic siddha unanitibb |
2015-May-18 |
|
155 KB |
| 115 |
DR_G.S.R. 289(E) dt_15.04.2015_Amendment Rule 74,74A,74B, 78,78A_No Advertisement for Sch H, H1, X Drugs |
2015-Apr-15 |
|
147 KB |
| 116 |
2015.03.30_S.O. 873(E) Bank of Baroda 11 branches |
2015-Mar-30 |
|
500 KB |
| 117 |
DR_G.S.R. 203(E) dt_18.03.2015_Amendment Sch S, SchQ |
2015-Mar-18 |
|
68 KB |
| 118 |
DR_G.S.R. 107(E) dt_17.02.2015_Amendment Schedule K_Words ommited in Form 20C |
2015-Feb-17 |
|
1121 KB |
| 119 |
2014.12.29_S.O. 3298 (E) _Reconstitution of DTAB |
2014-Dec-29 |
|
185 KB |
| 120 |
DR_G.S.R. 889(E) dt_12.12.2014_Amendment Rule 122DAB, Schedule Y & Appendix XII |
2014-Dec-12 |
|
184 KB |
| 121 |
2014.10.13 SO 2617 (E) dated 13.10.2014 notification of drugs inspector |
2014-Oct-13 |
|
176 KB |
| 122 |
DR_G.S.R. 718(E) dt_13.10.2014_Insertion of 134A_Prohibition of import of cosmetics tested on animals |
2014-Oct-13 |
|
168 KB |
| 123 |
DR_G.S.R. 690(E) dt_25.09.2014_Exemptions and labelling requirements of Medical devices |
2014-Sep-25 |
|
222 KB |
| 124 |
DR_G.S.R. 570(E) dt_07.08.2014_Ammendment Rule 71, 71A, 71B,76, 76A_API in proper or generic name |
2014-Aug-07 |
|
180 KB |
| 125 |
DR_G.S.R. 498(E) dt_11.07.2014_Prohibition of FDC_Flupenthixole and Melitracen |
2014-Jul-11 |
|
82 KB |
| 126 |
DR_G.S.R. 498(E) dt_11.07.2014_26A_reg FDC of Flupenthixol and Melitracen |
2014-Jul-11 |
|
82 KB |
| 127 |
DR_G.S.R. 346(E) dt_21.05.2014_Insertion of 148C_ Prohibition of testing of cosmetics on animals |
2014-May-21 |
|
69 KB |
| 128 |
DR_G.S.R. 86(E) dt_13.02.2014_Revoke GSR378(E)_Reg. Suspension of Analgin |
2014-Feb-13 |
|
83 KB |
| 129 |
DR_G.S.R. 29 (E) dt_17.01.2014_26A_Oxytocin supply to licensed Mfgrers and to Vet hospitals |
2014-Jan-17 |
|
90 KB |
| 130 |
2013.23.12_S.O. 3793(E)_Omissions of Sterile Word in section 3 (b) (iv)_amendment in notifcn S.O. 1468(E) dt 06.10.2005 |
2013-Dec-23 |
|
56 KB |
| 131 |
2013.11.07_S.O. 3395(E)_Notification for Appointment of Drugs Inspectors |
2013-Nov-07 |
|
227 KB |
| 132 |
DR_G.S.R. 724(E) dt_07.11.2013_amendment Rule 122E,Sch DHSX_Addition of Sindoor Ketamine |
2013-Nov-07 |
|
99 KB |
| 133 |
DR_G.S.R. 704(E) dt_25.10.2013_Amendment Rule 157_Ayurveda, Siddha, Unanai |
2013-Oct-25 |
|
87 KB |
| 134 |
DR_G.S.R. 588(E) dt_30.08.2013_Amendment Rule 65, Rule 97_Inclusion of Sch H1, Labelling requirements, Sch H list |
2013-Aug-30 |
|
182 KB |
| 135 |
DR_G.S.R. 520(E) dt_31.07.2013_Revoke GSR 379(E)_Reg.Pioglitazone Suspension |
2013-Jul-31 |
|
164 KB |
| 136 |
DR_G.S.R. 379 (E) dt_18.06.2013 _Suspension of manufacture, sale, distribution of Pioglitazone |
2013-Jun-18 |
|
55 KB |
| 137 |
DR_G.S.R. 377(E) dt_18.06.2013_26A_ Flupenthixol + Melitracen for human use |
2013-Jun-18 |
|
85 KB |
| 138 |
DR_G.S.R. 590(E) dt_08.30.2013_Corrigendum to GSR 332(E) 23.05.2013 |
2013-May-23 |
|
55 KB |
| 139 |
DR_G.S.R. 332(E) dt_23.05.2013_26A_reg Dextropropoxyphene |
2013-May-23 |
|
56 KB |
| 140 |
DR_G.S.R. 72(E) dt_08.02.2013_Addition of Rule 122DD_Registration of Ethics Committee |
2013-Feb-08 |
|
415 KB |
| 141 |
DR_G.S.R._63 dt_01.02.2013_Insertion of Rule 122DAC |
2013-Feb-01 |
|
1256 KB |
| 142 |
DR_G.S.R. 53(E) dt_30.01.2013_Addition Rule 122 DAB, Appendix XII_Death Compensation |
2013-Jan-30 |
|
596 KB |
| 143 |
2012.11.30_S.O. 2808(E)_Notification of GA of CDTL Mumbai |
2012-Nov-30 |
|
32 KB |
| 144 |
2012.11.30_S.O. 2809(E)_Notification of GA of CDTL Chennai |
2012-Nov-30 |
|
29 KB |
| 145 |
2012.11.30_S.O. 2810(E)_Notification of GA of CDL Kolkata |
2012-Nov-30 |
|
32 KB |
| 146 |
2012.10.19_S.O. 2527(E)_Notification of Subrat Kumar CDL kolkata |
2012-Oct-19 |
|
38 KB |
| 147 |
DR_G.S.R. 733(E) dt_29.09.2012_Corregendum of GSR 270(E) dt 30.03.2012 |
2012-Sep-29 |
|
22 KB |
| 148 |
2012.08.28_S.O. 1983(E)_Dr. Gyanendra Nath Singh, Sec. Cum Scietificd Directior,_ As LA under Rule 21(b) |
2012-Aug-28 |
|
19 KB |
| 149 |
DR_G.S.R. 575(E) dt_17.07.2012_Amendment to rule 43A_Addition of mumugao sea port and Goa , Bengaluru air port |
2012-Jul-17 |
|
56 KB |
| 150 |
DR_G.S.R. 574(E) dt_17.07.2012_amendment Rule 75A, 76A,78A, 83A, 83AA,Schedule A |
2012-Jul-17 |
|
131 KB |
| 151 |
DR_G.S.R. 432(E) dt_07.06.2012_26A_Banning of SeroDiagnostic Kits for diagnosis of tuberculosis |
2012-Jun-07 |
|
21 KB |
| 152 |
DR_G.S.R. 433(E) dt_07.06.2012_Amendment to GSR 577E_Addition of prohibition of Import of Serodiagnostic test kit for TB |
2012-Jun-07 |
|
25 KB |
| 153 |
2012.05.31_S.O. 1261(E)_Dr. Gyanendra Nath Singh, Sec. Cum Scietificd Directior,_ As LA under Rule 21(b) |
2012-May-31 |
|
20 KB |
| 154 |
DR_G.S.R. 270(E) dt_30.03.2012_Corregendum to GSR 733(E) dt 29.09.2011 |
2012-Mar-30 |
|
25 KB |
| 155 |
DR_G.S.R. 76(E) dt_08.02.2012_Amendment in Rule 127_Addition of Titanium Dioxide coated mica pearlscent pigments |
2012-Feb-08 |
|
45 KB |
| 156 |
DR_G.S.R. 28(E) dt_17.01.2012_Amendment in Rule 97_Labelling requirements for Food producing Animals |
2012-Jan-17 |
|
51 KB |
| 157 |
SO 2496(E) dt 03.11.2011_Notification of 19 Drugs Inspectors |
2011-Nov-03 |
|
175 KB |
| 158 |
DR_G.S.R. 752(E) dt_12.10.2011_Suspension of Letrozole for induction of Ovulation |
2011-Oct-12 |
|
78 KB |
| 159 |
DR_G.S.R. 418(E) dt_30.05.2011_26A_reh Human Placental Extracts (HPE) |
2011-May-30 |
|
79 KB |
| 160 |
DR_G.S.R.218(E) dt_16.03.2011_26A_reg Gatifloxacin and its formulations, Tegaserod and its formulations |
2011-Mar-16 |
|
75 KB |
| 161 |
DR_G.S.R. 82(E) dt 10.02.2011_26A_Reg Nimesulide, Cisapride, Phenylpropanolamine, HPE and Sibutramine |
2011-Feb-10 |
|
41 KB |
| 162 |
DR_G.S.R. 45(E) dt_24.01.2011_Amendment Rule 122E_Addition of Vaccines and r-DNA |
2011-Jan-24 |
|
79 KB |
| 163 |
DR_G.S.R. 910(E) dt_12.11.2010_26A_Rosiglitazone and its formulations |
2010-Nov-12 |
|
44 KB |
| 164 |
DR_G.S.R. 337(E) dt_15.04.2010_Amendment in Schedule I_Ayurvedic , Siddha Pharmacopoeia and its parts |
2010-Apr-15 |
|
81 KB |
| 165 |
DR_G.S.R. 86(E) dt_19.02.2010_Recruitement rules for DIs |
2010-Feb-19 |
|
229 KB |
| 166 |
DR_G.S.R. 917(E) dt_22.12.2009_Amendment in Schedule K_addition of Homeopathic Hair oils |
2009-Dec-22 |
|
51 KB |
| 167 |
DR_G.S.R. 884(E) dt_11.12.2009_10A_10. Rimonabant |
2009-Dec-11 |
|
27 KB |
| 168 |
DR_G.S.R. 885(E) dt_11.12.2009_26A_ 60. Rimonabant |
2009-Dec-11 |
|
46 KB |
| 169 |
SO 3077(E) dt 29.10.2009_Notification of (9) Drugs Inspectors |
2009-Oct-29 |
|
461 KB |
| 170 |
DR_G.S.R. 677(E) dt_15.09.2009_Restriction for Oseltamivir Phosphate and Zanamivir |
2009-Sep-15 |
|
1314 KB |
| 171 |
DR_G.S.R. 738(E) dt_09.10.2009_26A_reg FDC of corticosteroid with any other drug in Metered Dose Inhalers and Dry powder inhalers |
2009-Sep-10 |
|
57 KB |
| 172 |
DR_G.S.R. 651(E) dt_09.09.2009_Amendment Rule 3A_CDTL, chennai notified for Condoms |
2009-Sep-09 |
|
68 KB |
| 173 |
DR_G.S.R. 607(E) dt_28.08.2009_corregendum of GSR 46(E) dt 22.01.2009 |
2009-Jan-22 |
|
31 KB |
| 174 |
DR_G.S.R. 780(E) dt_10.11.2008_Amendment Rule 74,78,150E_Implimentation of Sch-L1 |
2008-Nov-10 |
|
408 KB |
| 175 |
DR_G.S.R. 499(E) dt_04.07.2008_26A_Diclofenac and its formulations |
2008-Jul-04 |
|
478 KB |
| 176 |
DR_G.S.R. 290(E) dt_16.04.2008_26A_reg FDCs of Salbutamol or any other drug |
2008-Apr-16 |
|
116 KB |
| 177 |
DR_G.S.R. 678(E) dt_31.10.2006_Schedule M-I |
2006-Oct-31 |
|
539 KB |
| 178 |
DR_G.S.R. 160(E) dt_16.03.2006_Schedule H inclusion of drugs sr. no 1 to 536 |
2006-Mar-16 |
|
300 KB |
| 179 |
DR_G.S.R. 26(E) dt_19.01.2006_Amendment Rule 69, 75,76, 122B& Sch A_Additional Fee, Addition of r-DNA |
2006-Jan-19 |
|
88 KB |
| 180 |
DR_G.S.R. 734(E) dt_21.12.2005_Amendment Schedule K_Production of Oxygen 93 percent |
2005-Dec-21 |
|
61 KB |
| 181 |
DR_G.S.R. 733(E) dt_21.12.2005_Amendment Rule 122F, 122G, Schedule F |
2005-Dec-21 |
|
65 KB |
| 182 |
DR_G.S.R. 510(E) dt_25.07.2005_26A_reg Valdecoxib and its formulations |
2005-Jul-25 |
|
55 KB |
| 183 |
DR_G.S.R. 431(E) dt_30.06.2005_Amendments in Schedule M |
2005-Jun-30 |
|
772 KB |
| 184 |
DR_G.S.R. 908(E) dt_22.12.2004_Ammendment Rule 3A_Tests notified for NIB |
2004-Dec-22 |
|
160 KB |
| 185 |
DR_G.S.R. 810(E) dt_13.12.2004_26A_reg Rofecoxib and its formulations |
2004-Dec-13 |
|
30 KB |
| 186 |
DR_G.S.R. 780(E) dt_01.10.2003_26A_Phenformin |
2003-Oct-01 |
|
37 KB |
| 187 |
DR_G.S.R. 191(E) dt_05.03.2003_26A_reg Astemizole and Terfinadine |
2003-Mar-05 |
|
35 KB |
| 188 |
DR_G.S.R. 100(E) dt_11.02.2003_26A_Reg FDC of Rifamicin, INH and Pyrazinamide |
2003-Feb-11 |
|
29 KB |
| 189 |
DR_G.S.R. 422(E) GSR 423(E) dt_11.06.2002_Rule 168& First Scedule |
2002-Jun-11 |
|
187 KB |
| 190 |
DR_G.S.R. 311(E) dt_01.05.2002_Amendment Rule 69,71,75,76_New Drug Approval |
2002-May-01 |
|
129 KB |
| 191 |
DR_G.S.R. 249(E) dt_04.04.2002_Amendment to Rule 3A_addition of NIB |
2002-Apr-04 |
|
107 KB |
| 192 |
DR_G.S.R. 900(E) dt_12.12.2001_Form 45 and others |
2001-Dec-12 |
|
856 KB |
| 193 |
DR_G.S.R. 604(E) dt_24.08.2001_Amendment to Part IV(rules)_Import and Registration |
2001-Aug-24 |
|
27182 KB |
| 194 |
DR_G.S.R. 603(E) dt_24.08.2001_26A_Reg FDC Metoclopramide and Aspirin+Paracetamol |
2001-Aug-24 |
|
68 KB |
| 195 |
DR_G.S.R. 170(E) dt_12.03.2001_26A_reg certain FDCs |
2001-Mar-12 |
|
83 KB |
| 196 |
DR_G.S.R. 169(E) dt_12.03.2001_26A_reg FDC of Diazepam and Diphenhydramine HCL |
2001-Mar-03 |
|
75 KB |
| 197 |
DR_G.S.R. 814(E) dt_16.12.1999_26A_reg FDC of Haemoglobin, FDC of Pancreatin or other enzymes etc |
1999-Dec-16 |
|
601 KB |
| 198 |
DR_G.S.R. 702(E) dt_14.10.1999_26A_reg combination of Vitamins (B1, B6 and B12) |
1999-Oct-14 |
|
63 KB |
| 199 |
DR_G.S.R. 395(E) dt_19.05.1999_26A_reg FDC of Metoclopramide and Aspirin, Paracetamol |
1999-May-19 |
|
75 KB |
| 200 |
DR_G.S.R. 245(E) dt_05.04.1999_Amendment to Rule 122_Requirements of blood bank |
1999-Apr-05 |
|
2627 KB |
| 201 |
DR_G.S.R. 499(E) dt_14.08.1998_26A_reg Mepacrine HCl and Fenfuramine & Dexfenfluramine |
1998-Aug-14 |
|
93 KB |
| 202 |
DR_G.S.R. 498(E) dt_14.08.1998_10A_reg Mepacrine HCl and Fenfuramine & Dexfenfluramine |
1998-Aug-14 |
|
69 KB |
| 203 |
DR_G.S.R. 242(E) dt_18.03.1998_Substitution Rule 3A_Functions of laboratories in respect of IUD |
1998-Mar-18 |
|
104 KB |
| 204 |
DR_G.S.R. 93(E) dt_25.02.1997_26A_Reg FDC of Streptomycin and Penicillins |
1997-Feb-25 |
|
66 KB |
| 205 |
DR_G.S.R. 552(E) dt_04.12.1996_Amendment to Rule 49_Proviso included |
1996-Dec-04 |
|
244 KB |
| 206 |
DR_G.S.R. 793(E) dt_13.12.1995_26A-reg FDC of Hydroxyquinoline group of drugs with any other drug |
1995-Dec-13 |
|
117 KB |
| 207 |
DR_G.S.R. 633(E) dt_13.09.1995_26A_Reg certain FDCs(Oxyphenbutazone, Analgin etc) |
1995-Sep-13 |
|
103 KB |
| 208 |
DR_G.S.R. 57(E) dt_07.02.1995_26A_Reg ORS solution |
1995-Feb-07 |
|
140 KB |
| 209 |
DR_G.S.R. 731(E) dt_30.09.1994_26A_reg Kaolin, phenyl sulphadiazole, neomycin etc |
1994-Sep-30 |
|
108 KB |
| 210 |
DR_G.S.R. 658(E) dt_31.08.1994_Amendment to First Schedule_Substitution Book name |
1994-Aug-31 |
|
218 KB |
| 211 |
DR_G.S.R. 658(E) dt_19.10.1993_ Rule 49_Qulaification of Inspectors |
1993-Oct-19 |
|
214 KB |
| 212 |
DR_G.S.R. 443(E) dt_30.04.1992_33 (EED))reg prohibition of all Ayuvedic drugs licensed as toothpastes, tooth powders containign tobacco |
1992-Apr-30 |
|
59 KB |
| 213 |
DR_G.S.R. 444(E) dt_30.04.1992_26A_reg all cosmetics licensed as tooth pastes, tooth powders containing tobacco |
1992-Apr-30 |
|
96 KB |
| 214 |
DR_G.S.R. 445(E) dt_30.04.1992_Substitution Rule 3A_functions of laboratories in respect of drugs and OPV |
1992-Apr-30 |
|
197 KB |
| 215 |
DR_G.S.R 304 (E) dt_07.06.1991_26A_Prohibition of Mfr of (i) FDC ergot preps and (ii) Chloral Hydrate |
1991-Jun-07 |
|
91 KB |
| 216 |
DR_G.S.R 303 (E) dt_07.06.1991_10A_Prohibition of import of Chloral Hydrate as a drug |
1991-Jun-07 |
|
76 KB |
| 217 |
DR_G.S.R. 69(E) dt_11.02.1991_26A_reg certain FDCs |
1991-Feb-11 |
|
131 KB |
| 218 |
DR_G.S.R. 999(E) dt_21.12.1990_26A_Reg certain FDC Sedative hypnotics with analgesics, pyrazinamide with anti TB drugs etc |
1990-Dec-21 |
|
129 KB |
| 219 |
DR_G.S.R. 743(E) dt_10.08.1989_ Prohibition of Oestroge and progesterone |
1989-Aug-10 |
|
2271 KB |
| 220 |
DR_G.S.R. 365(E) dt_17.03.1989_Notifying Disposable hypodermic syringes needles and perfusion set as drugs |
1989-Mar-17 |
|
166 KB |
| 221 |
DR_G.S.R. 1057(E) dt_03.11.1988_26A_sr. no 11 (FDC corticosteroids+any other drug) and 15(FDC Chloramphenicol with any other drug) |
1988-Nov-03 |
|
94 KB |
| 222 |
DR_G.S.R. 735(E) dt_28.08.1987_Amendment to First Schedule_Insertion of Books |
1987-Aug-28 |
|
86 KB |
| 223 |
DR_G.S.R. 322(E) dt_03.05.1984_26A_reg Oxytetracycline liquid oral prep and Demeclocycline Liqiod oral prep |
1984-May-03 |
|
77 KB |
| 224 |
DR_G.S.R. 299(E) dt_23.04.1984_Substitution in Second schedule_Class of drugs like vaccines, sera, toxines |
1984-Apr-23 |
|
103 KB |
| 225 |
DR_G.S.R. 49(E) dt_31.01.1984_26A_Prohibition of manufacture of Methaqualone |
1984-Jan-31 |
|
68 KB |
| 226 |
DR_G.S.R. 48(E) dt_31.01.1984_10A_Prohibition of import of Methaqualone |
1984-Jan-31 |
|
62 KB |
| 227 |
DR_G.S.R. 578(E) dt_23.09.1983__26A_Reg certain drugs and FDCs(amidopyrine, vit+tranquilisers etc |
1983-Sep-23 |
|
123 KB |
| 228 |
DR_G.S.R. 478(E) dt 06.08.1981_insertion of rule 43A |
1981-Aug-06 |
|
80 KB |
| 229 |
DR_G.S.R. 930(E) dt_13.07.1978_Amendment in Sch V for Standards of patent or proprietary medicines containing vitamins |
1978-Jul-13 |
|
294 KB |
